Showing results (1-10 of 754) with videos related to

Sort By:
Pageof 76
Biomaterials|July 5, 2019
T cell immunotherapy enhanced by designer biomaterialsZachary S Dunn, John Mac, Pin Wang
Theranostics|November 8, 2019
Quantitative Proteomics and Metabolomics Reveal Biomarkers of Disease as Potential Immunotherapy Targets and Indicators of Therapeutic EfficacyMelanie A MacMullan, Zachary S Dunn, Nicolas Graham, et al.
Human Gene Therapy|February 28, 2023
Secretion of 4-1BB Ligand Crosslinked to PD-1 Checkpoint Inhibitor Potentiates Chimeric Antigen Receptor T Cell Solid Tumor EfficacyZachary S Dunn, Yun Qu, Melanie MacMullan, et al.
RSC Advances|June 13, 2017
Co-delivery of carboplatin and paclitaxel via cross-linked multilamellar liposomes for ovarian cancer treatmentXiaoyang Zhang, Yarong Liu, Yu Jeong Kim, et al.
Human Gene Therapy|July 6, 2021
Adenosine Deaminase 1 Overexpression Enhances the Antitumor Efficacy of Chimeric Antigen Receptor-Engineered T CellsYun Qu, Zachary S Dunn, Xianhui Chen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 19, 2017
Combination Cancer Therapy Using Chimeric Antigen Receptor-Engineered Natural Killer Cells as Drug CarriersElizabeth L Siegler, Yu Jeong Kim, Xianhui Chen, et al.
Molecular Therapy Oncolytics|May 13, 2021
Secretion of bispecific protein of anti-PD-1 fused with TGF-β trap enhances antitumor efficacy of CAR-T cell therapyXianhui Chen, Shuai Yang, Si Li, et al.
The Journal of Biological Chemistry|May 30, 2019
Inhibition of nucleotide synthesis promotes replicative senescence of human mammary epithelial cellsAlireza Delfarah, Sydney Parrish, Jason A Junge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2017
Enhanced Cancer Immunotherapy by Chimeric Antigen Receptor-Modified T Cells Engineered to Secrete Checkpoint InhibitorsSi Li, Natnaree Siriwon, Xiaoyang Zhang, et al.
Biotechnology and Bioengineering|July 28, 2020
Generation of highly selective monoclonal antibodies inhibiting a recalcitrant protease using decoy designsKi Baek Lee, Zachary S Dunn, Tyler Lopez, et al.
Pageof 76